By way of an ordinary resolution passed on 12 May 2022 the Directors of the Company have general authority to make market purchases of up to 75,014,457 ordinary shares, being 14.99% of the ordinary shares in issue as at 28 March 2022, being the latest practicable date prior to the publication of the Company's Annual Report and Financial Statements for the year ended 31 January 2022. This authority will expire at the conclusion of the Annual General Meeting of the Company to be held in respect of the year ending 31 January 2023. No shares have been bought back during the six months ended 31 July 2022 (31 July 2021 – nil) hence the authority remains at 75,014,457 ordinary shares.
Holders of ordinary shares have the right to receive income and capital from assets attributable to such share class. Ordinary shareholders have the right to receive notice of general meetings of the Company and have the right to attend and vote at all general meetings.
Holders of C shares have the right to receive income and capital from assets attributable to such share class. C shareholders have the right to receive notice of general meetings of the Company and have the right to attend and vote at all general meetings.
During the period the Company incurred transaction costs on purchases of investments of US$57,000 (31 July 2021 – US$99,000; 31 January 2022 – US$99,000) and transaction costs on sales of US$nil (31 July 2021 – USnil; 31 January 2022 – USnil).
There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have such an effect on the Company during that period.
None of the views expressed in this document should be construed as advice to buy or sell a particular investment.